XXI Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.88M Buy
30,096
+14,039
+87% +$887K 0.75% 29
2026
Q2
$925K Buy
16,057
+938
+6% +$53.9K 0.43% 56
2026
Q1
$917K Buy
15,119
+9,585
+173% +$559K 0.52% 49
2025
Q4
$299K Buy
+5,534
New +$266K 0.18% 138

Other funds holding BMY

XXI Wealth's BMY Position: Q3 2026 in Review

XXI Wealth increased its Bristol-Myers Squibb (BMY) stake by 87% in Q3 2026, buying an estimated $887K and bringing the position to 30,096 shares worth $1.88M. The position accounts for 0.75% of the portfolio, ranked #29.

XXI Wealth first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,283 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • XXI Wealth held 30,096 shares of Bristol-Myers Squibb worth $1.88M as of Q3 2026.
  • XXI Wealth bought 14,039 Bristol-Myers Squibb shares in Q3 2026, an estimated $887K.
  • Bristol-Myers Squibb made up 0.75% of XXI Wealth's portfolio in Q3 2026, its #29 holding.
  • XXI Wealth first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 2,283 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.